Tofacitinib Prodrug-1 is an effective and oral active prodrug to mitigate the systemic adverse effects of Tofacitinib. Tofacitinib Prodrug-1 can effectively attenuate the oxazolone-induced colitis in mice model with low toxicity. Tofacitinib Prodrug-1 is a potential drug candidate for the treatment of ulcerative colitis .
Molecular Weight:
759.21
Formula:
C36H39ClN10O7
Target:
Others|||Apoptosis|||JAK
T72406
* VAT and and shipping costs not included. Errors and price changes excepted